Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
Rabbit Polyclonal Anti-ACTB Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human ACTB |
TA349205 is a possible alternative to TA349208.
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Goat Polyclonal Antibody against DKK1
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CDHHQASNSSRLHT, from the C Terminus of the protein sequence according to NP_036374. |
Goat Polyclonal Anti-CD4 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within 50 to 235 aa, corresponding to the external domain of human CD4 produced in E. coli. |
Rabbit polyclonal Neuro D (Ser274) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Neuro D around the phosphorylation site of serine 274 (P-L-SP-P-P). |
| Modifications | Phospho-specific |
Rabbit Polyclonal CD44 (Ser706) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CD44 around the phosphorylation site of Serine 706 |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CD31 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 690 aa to the C-terminus of human CD31 produced in E. coli. |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CDH1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified Recombinant peptide derived from within residues 601 to 701 of human CDH1 produced in E. coli. |
Rabbit Polyclonal STAT5A (Ser780) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human STAT5A around the phosphorylation site of Serine 780 |
| Modifications | Phospho-specific |
Rabbit Polyclonal STAT5A/B (Ser725/730) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human STAT5A/B around the phosphorylation site of Serine 725/730 |
| Modifications | Phospho-specific |
Goat Polyclonal Antibody against Tafazzin
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-HLKTQAEQLHNH, from the C Terminus of the protein sequence according to NP_000107.1; NP_851828.1; NP_851829.1; NP_851830.1. |
Rabbit Polyclonal GATA3 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | GATA3 antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human GATA3. The immunogen is located within amino acids 340 - 390 of GATA3. |
Rabbit anti-STAT5A (Phospho-Tyr694) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT5A around the phosphorylation site of tyrosine 694 (D-G-YP-V-K). |
| Modifications | Phospho-specific |
Phospho-KDR-Y1175 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A phospho specific peptide corresponding to residues surrounding Y1175 of human KDR |
| Modifications | Phospho-specific |
Rabbit Polyclonal c-Jun (Ser73) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human c-Jun around the phosphorylation site of Serine 73 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Anti-ACTB Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein of human ACTB |
Rabbit polyclonal Akt (Ab-129) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of serine 129 (D-N-SP-G-A). |
Rabbit polyclonal Akt (Ab-326) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of tyrosine 326 (N-D-YP-G-R). |
Rabbit Polyclonal Akt (Thr308) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Akt around the phosphorylation site of Threonine 308 |
| Modifications | Phospho-specific |
Rabbit Polyclonal C/EBP- beta (Thr235/188) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human C/EBP- beta around the phosphorylation site of Threonine 235/188 |
| Modifications | Phospho-specific |
Rabbit Polyclonal AML1 (Ser276) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human AML1 around the phosphorylation site of Serine 276 |
| Modifications | Phospho-specific |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Rat
Applications
- WB
Clonalities
- Polyclonal
Conjugates
- Unconjugated
Families
- ES Cell Differentiation/IPS
Availabilities
- In Stock
Filter by
Target Symbol
- EGFR (18)
- AKT1 (16)
- JUN (13)
- SRC (10)
- CTNNB1 (8)
- PDGFRB (8)
- PRKCA (8)
- STAT5A (8)
- MAPK3 (7)
- RUNX1 (7)
- BCL2L1 (6)
- GAPDH (6)
- SMAD3 (6)
- ACTB (5)
- MAPK8 (5)
- STAT5B (5)
- TNNI3 (5)
- CASP3 (4)
- CEBPA (4)
- GATA1 (4)
- GATA4 (4)
- HNF1B (4)
- PTPRC (4)
- SMAD1 (4)
- ACE (3)
- ANGPT1 (3)
- CSNK1A1 (3)
- ITGB3 (3)
- SMAD2 (3)
- TUBB3 (3)
- VIM (3)
- A1BG (2)
- ACTN1 (2)
- AKT2 (2)
- ALDH1A1 (2)
- BCL2 (2)
- BSG (2)
- CD44 (2)
- CDH1 (2)
- CDX2 (2)
- CSNK2A1 (2)
- CYP3A4 (2)
- INS (2)
- ITGB1 (2)
- KDR (2)
- NKX2-1 (2)
- NOTCH1 (2)
- PDGFRA (2)
- PDX1 (2)
- SOX1 (2)
- SOX7 (2)
- SP1 (2)
- STAT6 (2)
- ABCB1 (1)
- ACVR1 (1)
- ALCAM (1)
- ANGPTL2 (1)
- APH1A (1)
- AXIN2 (1)
- BDNF (1)
- BMP2 (1)
- CCN1 (1)
- CCN3 (1)
- CCR5 (1)
- CD4 (1)
- CD69 (1)
- CDH2 (1)
- CEBPB (1)
- CHRDL1 (1)
- CSPG5 (1)
- CST3 (1)
- CXCR4 (1)
- DHH (1)
- DKK1 (1)
- DKK4 (1)
- DLX5 (1)
- EGF (1)
- EMX1 (1)
- ENPEP (1)
- FCGR2A (1)
- FGF18 (1)
- FLT3 (1)
- FOXA1 (1)
- FOXA2 (1)
- GATA3 (1)
- GCG (1)
- GDF3 (1)
- GDF9 (1)
- GFAP (1)
- GLP1R (1)
- GREM1 (1)
- HCRTR1 (1)
- HES5 (1)
- HNF1A (1)
- HNF4A (1)
- ICAM1 (1)
- ID4 (1)
- IGFBP1 (1)
- IL10 (1)
- IL2RA (1)
Antibody Hosts
Modifications
Pathways
- Pathways in cancer (146)
- Focal adhesion (116)
- Colorectal cancer (97)
- ErbB signaling pathway (94)
- MAPK signaling pathway (87)
- Prostate cancer (67)
- Adherens junction (65)
- Pancreatic cancer (65)
- Glioma (62)
- GnRH signaling pathway (62)
- Chronic myeloid leukemia (57)
- Gap junction (57)
- Melanoma (57)
- Endometrial cancer (56)
- Wnt signaling pathway (55)
- Acute myeloid leukemia (53)
- Regulation of actin cytoskeleton (53)
- Tight junction (53)
- Non-small cell lung cancer (52)
- Epithelial cell signaling in Helicobacter pylori infection (51)
- Neurotrophin signaling pathway (47)
- T cell receptor signaling pathway (45)
- VEGF signaling pathway (45)
- Toll-like receptor signaling pathway (44)
- Jak-STAT signaling pathway (41)
- Endocytosis (40)
- Cytokine-cytokine receptor interaction (39)
- Fc epsilon RI signaling pathway (39)
- Renal cell carcinoma (39)
- B cell receptor signaling pathway (38)
- Fc gamma R-mediated phagocytosis (38)
- Calcium signaling pathway (36)
- Insulin signaling pathway (33)
- Progesterone-mediated oocyte maturation (33)
- Chemokine signaling pathway (32)
- Apoptosis (30)
- Leukocyte transendothelial migration (30)
- Bladder cancer (28)
- Pathogenic Escherichia coli infection (28)
- Small cell lung cancer (28)
- Dorso-ventral axis formation (27)
- mTOR signaling pathway (27)
- Melanogenesis (26)
- TGF-beta signaling pathway (26)
- Adipocytokine signaling pathway (25)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (23)
- Natural killer cell mediated cytotoxicity (20)
- Cell adhesion molecules (CAMs) (19)
- Hypertrophic cardiomyopathy (HCM) (19)
- Alzheimer's disease (18)
- Thyroid cancer (18)
- Type II diabetes mellitus (17)
- Dilated cardiomyopathy (16)
- Long-term depression (15)
- Long-term potentiation (15)
- Vascular smooth muscle contraction (15)
- Hematopoietic cell lineage (13)
- NOD-like receptor signaling pathway (13)
- Vibrio cholerae infection (13)
- Amyotrophic lateral sclerosis (ALS) (12)
- Basal cell carcinoma (12)
- Maturity onset diabetes of the young (12)
- Axon guidance (11)
- Metabolic pathways (11)
- Prion diseases (10)
- Viral myocarditis (10)
- Cell cycle (9)
- Oocyte meiosis (9)
- ECM-receptor interaction (8)
- Phosphatidylinositol signaling system (8)
- Huntington's disease (7)
- Glycolysis / Gluconeogenesis (6)
- Hedgehog signaling pathway (6)
- RIG-I-like receptor signaling pathway (6)
- Cardiac muscle contraction (5)
- Notch signaling pathway (5)
- Primary immunodeficiency (5)
- Parkinson's disease (4)
- Renin-angiotensin system (4)
- Retinol metabolism (4)
- Systemic lupus erythematosus (4)
- p53 signaling pathway (4)
- Drug metabolism - cytochrome P450 (2)
- Drug metabolism - other enzymes (2)
- Linoleic acid metabolism (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- Neuroactive ligand-receptor interaction (2)
- Regulation of autophagy (2)
- Type I diabetes mellitus (2)
- ABC transporters (1)
- Allograft rejection (1)
- Antigen processing and presentation (1)
- Asthma (1)
- Autoimmune thyroid disease (1)
- Complement and coagulation cascades (1)
- Cysteine and methionine metabolism (1)
- Lysosome (1)
- Phenylalanine (1)
- Phenylalanine metabolism (1)
- Tyrosine metabolism (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)
- tyrosine and tryptophan biosynthesis (1)